Nifedipine Impurity 3

SZ目录编号:	SZ-N003011
CAS 号	113578-26-0
分子式	C20H24N2O6
分子量	388.4
投资状态	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: Methyl isobutyl 1, 4-dihydro2, 6-dimethyl-4-(3-nitrophenyl) pyridine 3, 5-dicarboxylate

异名: m-Nisoldipine

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCC(C)C

Rapid characterization of impurities in the bulk drug of nifedipine by high performance liquid chromatography-quadrupole time of fight mass spectrometry
Peixi Zhu 1, Lixi Ding, Jiajia He, Guogang Zheng
Se Pu. 2012 Oct;30(10):1026-30.

Development and validation of rp-hplc method for the estimation of process related impurity from nifedipine
Dr.Manisha. S. Kedar1* , Dr.Manoj. P. Shirbhate2 , Manjusha. S. Sanap3 , Dr.Rani. S. Kankate4 , Prerana. B. Jadhav5 and Bhagyashri. J. Warude
European Journal of Molecular & Clinical Medicine Volume 7, Issue 8, 2020; 5593-5601

Validation of an HPLC Method for Nifedipine and its Related Substances in Raw Materials
N. Beaulieu ,N. M. Curran,S. J. Graham,R. W. Sears &E. G. Lovering
Journal of Liquid Chromatography Volume 14, 1991 - Issue 6 Pages 1173-1183

Development and characterization of ethylcellulose based microsphere for sustained release of nifedipine
PatitapabanaParidaaSubash ChandraMishrabSubhashreeSahoocAjitBeheradBibhukalyan PrasadNayak
Journal of Pharmaceutical Analysis Volume 6, Issue 5, October 2016, Pages 341-344

Nifedipine Impurity 3 is chemically Methyl isobutyl 1, 4-dihydro2, 6-dimethyl-4-(3-nitrophenyl) pyridine 3, 5-dicarboxylate. It is also known as m-Nisoldipine. Nifedipine Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Nifedipine Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nifedipine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Nifedipine Impurity 3

Contacts

Our Locations

SZ目录编号:	: SZ-N003001
CAS 号	: 21829-25-4
分子式	: C17H18N2O6
分子量	: 346.3
投资状态	: In Stock

SZ目录编号:	: SZ-N003003
CAS 号	: 50428-14-3
分子式	: C17H16N2O5
分子量	: 328.3
投资状态	: In Stock

SZ目录编号:	: SZ-N003006
CAS 号	: 77234-00-5
分子式	: C17H17NO4
分子量	: 299.3
投资状态	: In Stock

SZ目录编号:	: SZ-N003002
CAS 号	: 67035-22-7
分子式	: C17H16N2O6
分子量	: 344.3
投资状态	: In Stock

SZ目录编号:	: SZ-N003004
CAS 号	: 39562-27-1
分子式	: C12H11NO5
分子量	: 249.2
投资状态	: In Stock

SZ目录编号:	: SZ-N003005
CAS 号	: 14205-39-1
分子式	: C5H9NO2
分子量	: 115.1
投资状态	: In Stock

SZ目录编号:	: SZ-N003007
CAS 号	: 114709-68-1
分子式	: C16H17N3O5
分子量	: 331.3
投资状态	: Out of Stock

SZ目录编号:	: SZ-N003008
CAS 号	: 80742-11-6
分子式	: C19H18N4O6
分子量	: 398.4
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003D01
CAS 号	: 1188266-14-9
分子式	: C17H12D6N2O6
分子量	: 352.4
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003009
CAS 号	: 53055-15-5
分子式	: C18H20N2O6
分子量	: 360.4
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003010
CAS 号	: 39562-82-8
分子式	: C19H22N2O6
分子量	: 374.4
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003011
CAS 号	: 113578-26-0
分子式	: C20H24N2O6
分子量	: 388.4
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003012
CAS 号	: 160233-03-4
分子式	: C27H36N4O9S
分子量	: 592.7
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003013
CAS 号	: 1332581-15-3
分子式	: C24H33N3O7S
分子量	: 507.6
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003014
CAS 号	: NA
分子式	: C25H35N3O7S
分子量	: 521.6
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-N003015
CAS 号	: NA
分子式	: C17H17N3O7
分子量	: 375.3
投资状态	: Inquire

SZ目录编号:	: SZ-N003016
CAS 号	: 108139-78-2
分子式	: C19H18N4O6
分子量	: 398.4
投资状态	: Custom Synthesis